Medical news & information, drug approvals & FDA & NIH medical research news. Information on prescribing drugs, patient education, infectious diseases, the pharmaceutical industry & biomedical news.



Vidyya Medical News Servicesm
Vidyya, from the Sanskrit "vaidya," a practitioner who has come to understand the science of life.

Volume 2 Published - 14:00 UTC    08:00 EST    23-March-2001      
Issue 82 Next Update - 14:00 UTC 08:00 EST    24-March-2001      

Vidyya Home  Vidyya

Home Of Our Sponsor, Vidyya.  Vidyya. Home

Vidyya Archives  Vidyya Archives

Search Vidyya  Search Vidyya

Visit Our Library  Ex Libris

Subscribe To Our News Service  Subscriptions

All About Us  About Vidyya



















Proceed To Article In Today's Vidyya
world
Tomorrow is World TB Day. Information is available on the World Health Organization's website at www.who.int.


Proceed To Article Tomorrow Is World TB Day -- 24 March 2001
Widely prescribed pain killers that provide relief with minimal side effects may have more pain-relieving properties than previously identified. A new study funded by the National Institute of Neurological Disorders and Stroke (NINDS) shows that non-steroidal anti-inflammatory drugs, or NSAIDs, not only relieve pain at the local (peripheral) site of inflammation but in fact affect the entire central nervous system. Results of the study appear in the 22 March 2001, issue of Nature. More...

Proceed To Article Evaluation Of A Directly Observed Therapy Short-Course Strategy For Treating Tuberculosis -- Orel Oblast, Russian Federation, 1999--2000
During the 1990s, the number of tuberculosis (TB) cases increased dramatically in the Russian Federation, and the rise paralleled concomitant increases in TB-associated mortality. In November 1998, the World Health Organization (WHO), the U.S. Agency for International Development, and CDC, in collaboration with the Central Tuberculosis Research Institute of the Russian Academy of Medical Sciences and the Russian Ministry of Health, identified three regions as demonstration sites for implementing a WHO control strategy program of directly observed treatment short-course (DOTS). The program was designed to provide comprehensive TB care to both civilian and prison populations within each region (oblast), and periodic cohort analyses of treatment outcomes were recommended to evaluate its progress. This report summarizes evaluations of treatment outcomes for patients enrolled during the first 6 months of the project. More...

Proceed To Article US Federal Government Makes Final Call for Data, Public Comment Before Writing New Report On Cancer-Causing Substances
Do estrogens, wood dust, a common solvent called trichloroethylene, the flavoring methyleugenol and the antibiotic chloramphenicol cause human cancer under some circumstances? The National Toxicology Program, headquartered at the National Institute of Environmental Health Sciences, is seeking final public comments and data on these and several other substances and exposures before recommending whether to list them as human carcinogens in the federal government's tenth and newest Report on Carcinogens. More...

Proceed To Article FDA Approves New Glucose Test For Adult Diabetics
The Food and Drug Administration today approved a wristwatch-like device that provides adult diabetics with more information for managing their disease. It is intended for use along with, not as a replacement for, finger-prick blood tests to monitor glucose. The GlucoWatch Biographer, made by Cygnus Inc., of Redwood City, Calif., extracts fluid through the skin by sending out tiny electric currents. Glucose levels are measured using this fluid every 20 minutes for 12 hours-even during sleep. More...

Proceed To Article

New Indication For Xenical® Sought By Roche Pharmaceuticals
Hoffmann-La Roche Inc. announced today that it has submitted a supplemental application to the U.S. Food and Drug Administration (FDA) for a new indication for its prescription weight loss medication Xenical® (orlistat) to improve glycemic control when used as an adjunct to other antidiabetic treatments in overweight or obese patients with type 2 diabetes.
More...


Vidyya. Home |  Ex Libris |  Vidyya  | 
Subscription Information |  About Vidyya |  Vidyya Archives | 

Editor: Susan K. Boyer, RN
© Vidyya. All rights reserved.

Medical news & information, drug approvals & FDA & NIH medical research news. Information on prescribing drugs, patient education, infectious diseases, the pharmaceutical industry & biomedical news.